Search Results - "Keil, D."

Refine Results
  1. 1

    Benefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates - A Retrospective Cohort Study by Patole, Sanjay K, Rao, Shripada C, Keil, Anthony D, Nathan, Elizabeth A, Doherty, Dorota A, Simmer, Karen N

    Published in PloS one (08-03-2016)
    “…Systematic reviews of randomised controlled trials report that probiotics reduce the risk of necrotising enterocolitis (NEC) in preterm neonates. To determine…”
    Get full text
    Journal Article
  2. 2

    Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia by Lam, Connie, Octavia, Sophie, Ricafort, Lawrence, Sintchenko, Vitali, Gilbert, Gwendolyn L, Wood, Nicholas, McIntyre, Peter, Marshall, Helen, Guiso, Nicole, Keil, Anthony D, Lawrence, Andrew, Robson, Jenny, Hogg, Geoff, Lan, Ruiting

    Published in Emerging infectious diseases (01-04-2014)
    “…Acellular vaccines against Bordetella pertussis were introduced in Australia in 1997. By 2000, these vaccines had replaced whole-cell vaccines. During…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial by Patole, Sanjay, Keil, Anthony D, Chang, Annie, Nathan, Elizabeth, Doherty, Dorota, Simmer, Karen, Esvaran, Meera, Conway, Patricia

    Published in PloS one (03-03-2014)
    “…Probiotic supplementation significantly reduces the risk of necrotising enterocolitis (NEC) and all cause mortality in preterm neonates. Independent quality…”
    Get full text
    Journal Article
  5. 5

    Obstetric and Neonatal Invasive Meningococcal Disease Caused by Neisseria meningitidis Serogroup W, Western Australia, Australia by Hart, Julie, Dowse, Gary K, Porter, Michelle, Speers, David J, Keil, Anthony D, Bew, Jane D, Mowlaboccus, Shakeel, Kahler, Charlene M

    Published in Emerging infectious diseases (01-02-2024)
    “…Three mother-baby pairs with invasive meningococcal disease occurred over 7 months in Western Australia, Australia, at a time when serogroup W sequence type 11…”
    Get full text
    Journal Article
  6. 6

    Evidence-based guidelines for use of probiotics in preterm neonates by Deshpande, Girish C, Rao, Shripada C, Keil, Anthony D, Patole, Sanjay K

    Published in BMC medicine (02-08-2011)
    “…Current evidence indicates that probiotic supplementation significantly reduces all-cause mortality and definite necrotising enterocolitis without significant…”
    Get full text
    Journal Article
  7. 7

    Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017 by Xu, Zheng, Octavia, Sophie, Luu, Laurence Don Wai, Payne, Michael, Timms, Verlaine, Tay, Chin Yen, Keil, Anthony D, Sintchenko, Vitali, Guiso, Nicole, Lan, Ruiting

    Published in Emerging infectious diseases (01-06-2019)
    “…During the 2008-2012 pertussis epidemic in Australia, pertactin (Prn)-negative Bordetella pertussis emerged. We analyzed 78 isolates from the 2013-2017…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The effect of a single early high-dose vitamin D supplement on fracture union in patients with hypovitaminosis D: a prospective randomised trial by Haines, N, Kempton, L B, Seymour, R B, Bosse, M J, Churchill, C, Hand, K, Hsu, J R, Keil, D, Kellam, J, Rozario, N, Sims, S, Karunakar, M A

    Published in The bone & joint journal (01-11-2017)
    “…To evaluate the effect of a single early high-dose vitamin D supplement on fracture union in patients with hypovitaminosis D and a long bone fracture. Between…”
    Get more information
    Journal Article
  10. 10

    Clonal Expansion of New Penicillin-Resistant Clade of Neisseria meningitidis Serogroup W Clonal Complex 11, Australia by Mowlaboccus, Shakeel, Jolley, Keith A, Bray, James E, Pang, Stanley, Lee, Yung Thin, Bew, Jane D, Speers, David J, Keil, Anthony D, Coombs, Geoffrey W, Kahler, Charlene M

    Published in Emerging infectious diseases (01-08-2017)
    “…In Western Australia, Neisseria meningitidis serogroup W clonal complex 11 became the predominant cause of invasive meningococcal disease in 2016. We used…”
    Get full text
    Journal Article
  11. 11

    Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia by Mowlaboccus, Shakeel, Mullally, Christopher A, Richmond, Peter C, Howden, Benjamin P, Stevens, Kerrie, Speers, David J, Keil, Anthony D, Bjørnstad, Ottar N, Perkins, Timothy T, Kahler, Charlene M

    Published in PloS one (24-10-2017)
    “…Neisseria meningitidis is the causative agent of invasive meningococcal disease (IMD). A recombinant vaccine called Bexsero® incorporates four subcapsular…”
    Get full text
    Journal Article
  12. 12

    Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia by Mowlaboccus, Shakeel, Perkins, Timothy T, Smith, Helen, Sloots, Theo, Tozer, Sarah, Prempeh, Lydia-Jessica, Tay, Chin Yen, Peters, Fanny, Speers, David, Keil, Anthony D, Kahler, Charlene M

    Published in PloS one (29-06-2016)
    “…Neisseria meningitidis is the causative agent of invasive meningococcal disease (IMD). The BEXSERO® vaccine which is used to prevent serogroup B disease is…”
    Get full text
    Journal Article
  13. 13

    Genomic dissection of the microevolution of Australian epidemic Bordetella pertussis by Xu, Zheng, Hu, Dalong, Luu, Laurence Don Wai, Octavia, Sophie, Keil, Anthony D., Sintchenko, Vitali, Tanaka, Mark M., Mooi, Frits R., Robson, Jenny, Lan, Ruiting

    Published in Emerging microbes & infections (01-12-2022)
    “…Whooping cough (pertussis) is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. Despite high vaccine coverage, pertussis…”
    Get full text
    Journal Article
  14. 14

    Riboflavin and UV-Light Based Pathogen Reduction: Extent and Consequence of DNA Damage at the Molecular Level by Kumar, Vijay, Lockerbie, Owen, Keil, Shawn D., Ruane, Patrick H., Platz, Matthew S., Martin, Christopher B., Ravanat, Jean-Luc, Cadet, Jean, Goodrich, Raymond P.

    Published in Photochemistry and photobiology (01-07-2004)
    “…We are developing a technology based on the combined application of riboflavin (RB) and light for inactivating pathogens in blood products while retaining the…”
    Get full text
    Journal Article
  15. 15

    RSV prophylaxis use in high-risk infants in Western Australia, 2002-2013: a record linkage cohort study by Xu, Ruomei, Fathima, Parveen, Strunk, Tobias, de Klerk, Nicholas, Snelling, Thomas L, Richmond, Peter C, Keil, Anthony D, Moore, Hannah C

    Published in BMC pediatrics (22-10-2020)
    “…The monoclonal antibody, palivizumab is licensed for use in high-risk infants to prevent severe illness caused by respiratory syncytial virus (RSV). The level…”
    Get full text
    Journal Article
  16. 16

    Multi-species bacterial biofilm and intracellular infection in otitis media by Thornton, Ruth B, Rigby, Paul J, Wiertsema, Selma P, Filion, Pierre, Langlands, Jennifer, Coates, Harvey L, Vijayasekaran, Shyan, Keil, Anthony D, Richmond, Peter C

    Published in BMC pediatrics (24-10-2011)
    “…Bacteria which are metabolically active yet unable to be cultured and eradicated by antibiotic treatment are present in the middle ear effusion of children…”
    Get full text
    Journal Article
  17. 17

    Genomic dissection of Australian Bordetella pertussis isolates from the 2008–2012 epidemic by Safarchi, Azadeh, Octavia, Sophie, Wu, Sunny Z, Kaur, Sandeep, Sintchenko, Vitali, Gilbert, Gwendolyn L, Wood, Nicholas, McIntyre, Peter, Marshall, Helen, Keil, Anthony D, Lan, Ruiting

    Published in The Journal of infection (01-04-2016)
    “…Summary Objectives Despite high pertussis vaccination coverage, Australia experienced a prolonged epidemic in 2008–2012. The predominant Bordetella pertussis…”
    Get full text
    Journal Article
  18. 18

    Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system by Vanlandingham, Dana L., Keil, Shawn D., Horne, Kate McElroy, Pyles, Richard, Goodrich, Raymond P., Higgs, Stephen

    Published in Transfusion (Philadelphia, Pa.) (01-02-2013)
    “…BACKGROUND: Chikungunya virus (CHIKV) is a reemerging mosquito‐borne virus that has been responsible for a number of large‐scale epidemics as well as imported…”
    Get full text
    Journal Article
  19. 19

    Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment by Keil, Shawn D., Bowen, Richard, Marschner, Susanne

    Published in Transfusion (Philadelphia, Pa.) (01-12-2016)
    “…BACKGROUND Middle East respiratory syndrome coronavirus (MERS‐CoV) has been identified as a potential threat to the safety of blood products. The Mirasol…”
    Get full text
    Journal Article
  20. 20

    Elaboration of a clinical and paraclinical score to estimate the probability of herpes simplex virus encephalitis in patients with febrile, acute neurologic impairment by Gennai, S., Rallo, A., Keil, D., Seigneurin, A., Germi, R., Epaulard, O.

    “…Herpes simplex virus (HSV) encephalitis is associated with a high risk of mortality and sequelae, and early diagnosis and treatment in the emergency department…”
    Get full text
    Journal Article